FindTrial
Sign In

Early and quick detection of pulmonary and extra pulmonary tuberculosis and resistance to one of the drugs used for treatment (rifampicin) using a real time PCR based assay (CB-NAAT)

Rapid detection of Mycobacterium tuberculosis complex and Rifampicin resistance in pulmonary and extra pulmonary tuberculosis using Cartridge Based Nucleic Acid Amplification test in Mangalore

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/09/007329
Enrollment
50
Registered
2016-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suspected of pulmonary and extra pulmonary tuberculosis and drug resistant tuberculosis

Interventions

Control Intervention1: nil: nil

Sponsors

Father Muller Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients highly suspected of having pulmonary and extrapulmonary tuberculosis and drug resistant tuberculosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1.To detect tuberculosis from respiratory and non respiratory specimens of patients with high clinical suspicion 2.To determine the prevalence of rifampicin resistance in new and previously treated pulmonary and extra pulmonary tuberculosis patients Timepoint: 1 year, 6 months—

Secondary

MeasureTime frame
To compare rifampicin resistant patients in terms of age, gender, socio- economic status, previous treatment history, contact with MDR-TB patients and immuno-compromised status.Timepoint: 1 year, 6 months—

Countries

India

Contacts

Public ContactDr Rekha B

Father Muller Medical College And Hospital

rekhaboloor@gmail.com9945265421

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026